NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News → BUY ALERT: Tiny tech play partners with US government (From Stansberry Research) (Ad) Buy IBBQ with Qtrade Free IBBQ Stock Alerts $21.90 +0.34 (+1.58%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$21.83▼$22.0450-Day Range$20.28▼$22.9852-Week Range$18.18▼$23.02Volume50,082 shsAverage Volume19,816 shsMarket Capitalization$32.19 millionAssets Under Management$32.21 millionDividend Yield0.82%Net Expense Ratio0.19% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get Invesco Nasdaq Biotechnology ETF alerts: Email Address About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More IBBQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBBQ ETF News HeadlinesMay 4, 2024 | finance.yahoo.comInvesco NASDAQ Biotech UCITS ETF (SBIO.SW)May 4, 2024 | americanbankingnews.comInvesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Shares Up 1.6%May 5, 2024 | Stansberry Research (Ad)BUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).April 1, 2024 | msn.comQQQ ETF Update, 4/1/2024February 27, 2024 | markets.businessinsider.comVestmark In Partnership With Invesco On Portfolio SolutionsJanuary 10, 2024 | markets.businessinsider.comAnalyst Expectations For Invesco's FutureJanuary 9, 2024 | msn.comBiotech ETFs Stage Solid Comeback at the Start of 2024December 20, 2023 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0526May 5, 2024 | Stansberry Research (Ad)BUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).December 4, 2023 | msn.comInvesco Advisors completes IHIT termination and liquidationSee More Headlines Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings223 Fund Statistics Assets Under Management$32.21 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Miscellaneous Outstanding Shares1,470,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.19%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.19%0.60%0.60%0.54%0.58% Invesco Nasdaq Biotechnology ETF (IBBQ) Holdings & ExposureTop 10 IBBQ HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.68%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.28%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.22%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.18%AstraZeneca(NASDAQ:AZN)Holding Weight: 4.51%Moderna(NASDAQ:MRNA)Holding Weight: 4.37%Biogen(NASDAQ:BIIB)Holding Weight: 3.19%Illumina(NASDAQ:ILMN)Holding Weight: 2.10%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 2.05%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 1.89%IBBQ Sector ExposureIBBQ Industry ExposureFull Holdings Details Similar ETFsPrincipal Healthcare Innovators ETFNASDAQ:BTECFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInstitutional OwnershipEudaimonia Advisors LLCBought 70,693 shares on 4/25/2024Ownership: 4.809%Eudaimonia Partners LLCBought 41,612 shares on 4/25/2024Ownership: 2.831%View All Institutional Transactions IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed in 2024? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 at the beginning of 2024. Since then, IBBQ shares have increased by 0.0% and is now trading at $21.90. View the best growth stocks for 2024 here. Are investors shorting Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF saw a increase in short interest in April. As of April 15th, there was short interest totaling 25,700 shares, an increase of 213.4% from the March 31st total of 8,200 shares. Based on an average daily trading volume, of 18,100 shares, the days-to-cover ratio is presently 1.4 days. View Invesco Nasdaq Biotechnology ETF's Short Interest. How often does Invesco Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF announced a quarterly dividend on Friday, March 15th. Shareholders of record on Tuesday, March 19th will be paid a dividend of $0.0435 per share on Friday, March 22nd. This represents a $0.17 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date is Monday, March 18th. Read our dividend analysis for IBBQ. What does IBBQ invest in? Invesco Nasdaq Biotechnology ETF is a equity fund issued by Invesco. IBBQ focuses on health care investments and follows the Nasdaq Biotechnology Index. The fund's investments total to approximately $32.21 million assets under management. What stocks does Invesco Nasdaq Biotechnology ETF hold? IBBQ invests in 223 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), AstraZeneca (AZN), Moderna (MRNA), Biogen (BIIB), Illumina (ILMN), Alnylam Pharmaceuticals (ALNY) and BioMarin Pharmaceutical (BMRN). What is the management fee for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for IBBQ is 0.19%. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Eudaimonia Advisors LLC (4.81%) and Eudaimonia Partners LLC (2.83%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBBQ) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
